Odyssey Therapeutics prices upsized IPO at $18 per share

Chronological Source Flow
Back

AI Fusion Summary

Odyssey Therapeutics, a biotech firm, upsized its U.S. IPO, raising $279 million. The company priced the offering at $18 per share, reflecting a higher valuation than initially planned for investors.
Community Comments
Loading updates...
0